World's Best Scientists 2026 revealed!
Quentin J. Sattentau

Quentin J. Sattentau

D-Index & Metrics

Immunology

D-Index
84
Citations
27238
World Ranking
1363
National Ranking
115

Quentin J. Sattentau publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Quentin J. Sattentau sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 241 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Quentin J. Sattentau D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Quentin J. Sattentau sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Quentin J. Sattentau is affiliated with the University of Oxford in the United Kingdom. Their research predominantly spans the fields of Medicine and Immunology and Microbiology, with a strong concentration in infectious diseases and viral studies.

Their main fields of study include:

  • Medicine
  • Immunology and Microbiology

Within these fields, their work has involved several subfields such as:

  • Infectious Diseases
  • Virology
  • Radiology, Nuclear Medicine and Imaging
  • Immunology
  • Molecular Biology

The key topics addressed in their research include:

  • HIV Research and Treatment
  • Monoclonal and Polyclonal Antibodies Research
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • COVID-19 Clinical Research Studies
  • HIV/AIDS drug development and treatment
  • Glycosylation and Glycoproteins Research

Quentin J. Sattentau has contributed to multiple publication venues. The most frequent outlets for their research include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Oxford Open Immunology
  • npj Vaccines
  • Nature Communications
  • Science Advances

Several recent papers illustrate the breadth of their research:

  • "Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses" (2022), published in Frontiers in Immunology
  • "Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization" (2021), published in Science Advances
  • "Macrophage Cell-Cell Interactions Promoting HIV-1 Infection" (2020), published in Viruses
  • "Pathogen-sugar interactions revealed by universal saturation transfer analysis" (2022), published in Science
  • "T cell phenotypes in COVID-19 - a living review" (2020), published in Oxford Open Immunology

Their research collaborations include frequent co-authors such as:

  • Lachlan P. Deimel
  • Charles Buchanan
  • Xiaochao Xue
  • James H. Naismith
  • Andrew J. Baldwin

Best Publications

  • A new classification for HIV-1

    E. A. Berger;R. W. Doms;E.-M. Fenyö;B. T. M. Korber

  • Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission

    Stefanie Sowinski;Clare Jolly;Otto Berninghausen;Marco A. Purbhoo

  • Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.

    Q J Sattentau;J P Moore

  • Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

    John P. Moore;Jane A. McKeating;Robin A. Weiss;Quentin J. Sattentau

  • HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse.

    Clare Jolly;Kirk Kashefi;Michael Hollinshead;Quentin J. Sattentau

  • Avoiding the void: cell-to-cell spread of human viruses

    Quentin Sattentau

  • Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.

    J. P. Moore;Yunzhen Cao;Limo Qing;Q. J. Sattentau

  • The CD4 antigen: physiological ligand and HIV receptor.

    Quentin J. Sattentau;Robin A. Weiss

  • Identification of the Residues in Human CD4 Critical for the Binding of HIV

    J Arthos;K C Deen;M A Chaikin;J A Fornwald

  • Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals

    Davide Corti;Johannes P. M. Langedijk;Andreas Hinz;Michael S. Seaman

  • Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.

    JL Rossio;MT Esser;K Suryanarayana;DK Schneider

  • Epitopes of the CD4 antigen and HIV infection.

    Quentin J. Sattentau;Angus G. Dalgleish;Robin A. Weiss;Peter C. L. Beverley

  • Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.

    Q J Sattentau;J P Moore;F Vignaux;F Traincard

  • Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.

    Quentin J. Sattentau;John P. Moore

  • Thymic stromal lymphopoietin–elicited basophil responses promote eosinophilic esophagitis

    Mario Noti;Elia D.Tait Wojno;Brian S. Kim;Mark C. Siracusa

  • The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.

    P. W. H. I Parren;J. P Moore;D. R Burton;Q. J Sattentau

  • Selective Interactions of Polyanions with Basic Surfaces on Human Immunodeficiency Virus Type 1 gp120

    Maxime Moulard;Hugues Lortat-Jacob;Isabelle Mondor;Guillaume Roca

  • V3: HIV's switch-hitter.

    Oliver Hartley;Per Johan Klasse;Quentin J. Sattentau;John P. Moore

  • Human Immunodeficiency Virus Type 1 Attachment to HeLa CD4 Cells Is CD4 Independent and gp120 Dependent and Requires Cell Surface Heparans

    Isabelle Mondor;Sophie Ugolini;Quentin J. Sattentau

  • CD4-Induced Conformational Changes in the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein: Consequences for Virus Entry and Neutralization

    Nancy Sullivan;Ying Sun;Quentin Sattentau;Markus Thali

Frequent Co-Authors

John P. Moore
John P. Moore Cornell University
David C. Montefiori
David C. Montefiori Duke University
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
Per Johan Klasse
Per Johan Klasse Cornell University
Joseph Sodroski
Joseph Sodroski Harvard Medical School
Pascal Poignard
Pascal Poignard Grenoble Alpes University
Jonathan L. Heeney
Jonathan L. Heeney University of Cambridge
Robin A. Weiss
Robin A. Weiss University College London
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career pathways. Many professionals consider transitioning from roles like Family Nurse Practitioner (FNP) to specialized positions such as Acute Care Nurse Practitioner (ACNP). Understanding how to make this shift is crucial, and resources on fnp to acnp transitions provide valuable guidance.

Accelerated programs are also popular among students looking to boost their qualifications quickly. The availability of accelerated fnp programs helps candidates fast-track their nursing careers while balancing other responsibilities.

For individuals without a nursing background, starting with foundational courses is important. Online options such as online adn programs for non nurses offer an accessible path into the nursing field, complementing immunology studies with practical healthcare skills.

Additionally, many students look for absn programs with high acceptance rates to enhance their eligibility and entry into nursing professions. These programs provide flexible opportunities for career advancement within healthcare and immunology sectors.

Best Scientists Citing Quentin J. Sattentau

Trending Scientists

Recently Published Articles